Alejandra Carvajal, SVP, Chief Legal Officer at Mersana Therapeutics, Inc. (MRSN), sold 3,330 shares at $0.66 ($2K) on 2025-01-14, disclosed to the SEC on 2025-01-15.
Scheduled sale ($2k) by SVP, Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MRSN | SELL | 2024-10-07 | $27K | — | Filing → |
| MRSN | SELL | 2024-01-17 | $12K | — | Filing → |
| MRSN | SELL | 2023-04-28 | $15K | — | Filing → |